We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AWK icon
226
American Water Works
AWK
$26.2B
$227K 0.01%
1,529
+564
+58% +$85.9K
MCO icon
227
Moody's
MCO
$90.7B
$224K 0.01%
+824
New +$247K
SNPS icon
228
Synopsys
SNPS
$79.9B
$224K 0.01%
+736
New +$222K
CRM icon
229
Salesforce
CRM
$141B
$223K 0.01%
1,353
+1,134
+518% +$200K
FISV
230
Fiserv Inc
FISV
$27.6B
$220K 0.01%
+2,476
New +$240K
LH icon
231
Labcorp
LH
$23.1B
$220K 0.01%
1,092
+486
+80% +$104K
BBWI icon
232
Bath & Body Works
BBWI
$4.26B
$215K 0.01%
8,000
-30,317
-79% -$1.32M
MA icon
233
Mastercard
MA
$487B
$214K 0.01%
+678
New +$233K
PLD icon
234
Prologis
PLD
$140B
$214K 0.01%
1,820
+747
+70% +$103K
AZO icon
235
AutoZone
AZO
$50B
$213K 0.01%
99
– –
CDNS icon
236
Cadence Design Systems
CDNS
$101B
$212K 0.01%
1,414
+791
+127% +$119K
AIG icon
237
American International
AIG
$41.4B
$210K 0.01%
4,107
+3,003
+272% +$174K
COF icon
238
Capital One
COF
$131B
$210K 0.01%
2,014
+1,185
+143% +$145K
ZBH icon
239
Zimmer Biomet
ZBH
$18.1B
$208K 0.01%
1,977
– –
CAE icon
240
CAE Inc
CAE
$7.93B
$207K 0.01%
+8,413
New +$208K
CMA
241
DELISTED
Comerica
CMA
$200K 0.01%
2,722
+1,056
+63% +$85.3K
MET icon
242
MetLife
MET
$60.3B
$200K 0.01%
3,184
+2,458
+339% +$163K
SBUX icon
243
Starbucks
SBUX
$124B
$200K 0.01%
2,621
+449
+21% +$34.5K
ADSK icon
244
Autodesk
ADSK
$45.8B
$193K 0.01%
1,120
+455
+68% +$87.5K
HCA icon
245
HCA Healthcare
HCA
$85.6B
$192K 0.01%
1,144
+803
+235% +$173K
ILMN icon
246
Illumina
ILMN
$28.8B
$190K 0.01%
1,057
+106
+11% +$27.1K
DLR icon
247
Digital Realty Trust
DLR
$64.2B
$186K 0.01%
1,433
-577
-29% -$79.7K
PRU icon
248
Prudential Financial
PRU
$41.1B
$186K 0.01%
+1,945
New +$206K
ALL icon
249
Allstate
ALL
$62.3B
$185K 0.01%
1,462
-3
-0.2% -$393
A icon
250
Agilent Technologies
A
$38.4B
$184K 0.01%
1,549
+408
+36% +$50.2K
8 9
10
11 12

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.